ADGRG1 and acute myeloid leukemia: In accordance, RNA‐seq data from Pabst et al revealed that the GPR56 high expressing group of AML patients had a poorer overall survival.9 In the present study, we found that overall survival in patients receiving intensive chemotherapy was affected by their GPR56 protein expression status at diagnosis, since patients with a high GPR56 expression as assessed by flow cytometry showed an inferior overall survival in univariate analysis.